Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rauh

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
ACS Chemical Biology|March 22, 2014
A special thematic compilation/special issue crossover with Biochemistry, Journal of Medicinal Chemistry, and ACS Medicinal Chemistry Letters focused on kinasesDaniel Rauh
ACS Chemical Biology|January 19, 2013
Chemical biology--current and next challengesDaniel Rauh
Bioorganic & Medicinal Chemistry|May 22, 2012
Change or be changed: reflections of the workshop 'Future in Medicinal Chemistry'Ruth Brenk, Daniel Rauh
Angewandte Chemie (International Ed. in English)|December 30, 2006
Linking chemistry and biology for the study of protein functionDaniel Rauh, Herbert Waldmann
Methods in Enzymology|November 18, 2014
FLiK: a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformationsJeffrey R Simard, Daniel Rauh
Chemmedchem|October 6, 2009
Chemical and structural biology to direct the repurposing of sulindacJeffrey R Simard, Daniel Rauh
Cell Chemical Biology|January 21, 2018
Try Me: Promiscuous Inhibitors Still Allow for Selective Targeted Protein DegradationMatthias P Müller, Daniel Rauh
Methods in Molecular Biology (Clifton, N.J.)|October 4, 2011
Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligandsJeffrey R Simard, Daniel Rauh
Chembiochem : a European Journal of Chemical Biology|July 22, 2010
RAF kinase inhibitors in cancer treatment: like a bull in a China shop?Armin Robubi, Herbert Waldmann, Daniel Rauh
ACS Medicinal Chemistry Letters|August 22, 2018
C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?Tobias Grabe, Jonas Lategahn, Daniel Rauh
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
ACS Chemical Biology|March 22, 2014
A special thematic compilation/special issue crossover with Biochemistry, Journal of Medicinal Chemistry, and ACS Medicinal Chemistry Letters focused on kinasesDaniel Rauh
ACS Chemical Biology|January 19, 2013
Chemical biology--current and next challengesDaniel Rauh
Bioorganic & Medicinal Chemistry|May 22, 2012
Change or be changed: reflections of the workshop 'Future in Medicinal Chemistry'Ruth Brenk, Daniel Rauh
Angewandte Chemie (International Ed. in English)|December 30, 2006
Linking chemistry and biology for the study of protein functionDaniel Rauh, Herbert Waldmann
Methods in Enzymology|November 18, 2014
FLiK: a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformationsJeffrey R Simard, Daniel Rauh
Chemmedchem|October 6, 2009
Chemical and structural biology to direct the repurposing of sulindacJeffrey R Simard, Daniel Rauh
Cell Chemical Biology|January 21, 2018
Try Me: Promiscuous Inhibitors Still Allow for Selective Targeted Protein DegradationMatthias P Müller, Daniel Rauh
Methods in Molecular Biology (Clifton, N.J.)|October 4, 2011
Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligandsJeffrey R Simard, Daniel Rauh
Chembiochem : a European Journal of Chemical Biology|July 22, 2010
RAF kinase inhibitors in cancer treatment: like a bull in a China shop?Armin Robubi, Herbert Waldmann, Daniel Rauh
ACS Medicinal Chemistry Letters|August 22, 2018
C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?Tobias Grabe, Jonas Lategahn, Daniel Rauh
Pageof 16